Sansure Biotech's Group A Streptococcus Nucleic Acid Detection Kit Receives Medical Device Registration Certificate

Product / Tech
โดย 科创板日报·Read original
Summary · why it matters

Sansure Biotech announced that its Group A Streptococcus Nucleic Acid Detection Kit (Fluorescent PCR Method) has recently obtained a Medical Device Registration Certificate from the National Medical Products Administration. The kit is used for in vitro qualitative detection of Group A Streptococcus nucleic acid in human throat swab samples. It can be combined with the company's rapid nucleic acid detection solution for respiratory infections to achieve simultaneous multi-pathogen detection, helping to improve early diagnosis efficiency and standardize antimicrobial use.

Impact on stocks 1

Others▲ · 1 stocks
Sansure Biotech Inc
688289
▲ PositiveTechnologyrelevance

Sansure Biotech received regulatory approval for a new Group A Streptococcus nucleic acid detection kit, expanding its product portfolio.

© 2026 MarketDXNews